Jul 23, 2026 04:06PM
Jul 21, 2026 04:06PM
Jul 13, 2026 07:41AM
Jul 13, 2026 07:34AM
Jun 22, 2026 09:29AM
Jun 15, 2026 04:11PM
Jun 15, 2026 04:06PM Neurocrine Biosciences (NBIX) Presents First Retrospective Case Series of CRENESSITY
Jun 15, 2026 08:36AM
Jun 15, 2026 08:30AM
Jun 8, 2026 04:05PM
Jun 8, 2026 08:31AM
Jun 5, 2026 08:59AM
Jun 3, 2026 08:31AM
Jun 2, 2026 05:07AM Goldman Sachs Resumes Neurocrine Bio. (NBIX) at Buy
May 21, 2026 04:37PM
May 18, 2026 04:06PM
May 6, 2026 01:16PM
May 6, 2026 08:32AM
May 6, 2026 06:33AM
May 6, 2026 06:12AM
May 5, 2026 04:14PM Neurocrine Biosciences (NBIX) Tops Q1 EPS by 77c, Beats on Revenue
May 1, 2026 04:06PM
Apr 29, 2026 04:07PM
Apr 22, 2026 04:05PM
Apr 14, 2026 08:32AM
Apr 10, 2026 06:06AM
Apr 8, 2026 07:13AM
Apr 7, 2026 05:01AM Neurocrine Bio. (NBIX) PT Raised to $242 at Citi
Apr 6, 2026 03:49PM
Apr 6, 2026 02:41PM
Apr 6, 2026 01:59PM
Apr 6, 2026 01:10PM
Apr 6, 2026 09:35AM
Apr 6, 2026 05:53AM
Mar 26, 2026 08:33AM Neurocrine presents tardive dyskinesia treatment guidance for elderly
Mar 17, 2026 04:09PM
Mar 10, 2026 09:22AM
Feb 24, 2026 09:07AM
Feb 24, 2026 08:53AM
Feb 17, 2026 09:45AM
Feb 17, 2026 09:27AM
Feb 12, 2026 07:26AM Canaccord Genuity Reiterates Buy Rating on Neurocrine Bio. (NBIX)
Feb 12, 2026 07:11AM
Feb 11, 2026 04:04PM
Jan 30, 2026 10:08AM
Jan 15, 2026 08:32AM
Jan 12, 2026 06:26AM
Jan 8, 2026 08:49AM
Jan 8, 2026 03:39AM Morgan Stanley Downgrades Neurocrine Bio. (NBIX) to Equalweight
Jan 5, 2026 09:15AM

423,217 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All